FDA

New dosages, dosage forms of drugs to treat Alzheimer's dementia

Dear List-mates: Although there have been strides made in the diagnosis of Alzheimer's disease, there is nothing shown to prevent the disease and precious little to effectively treat it.  Nevertheless, that has not prevented PhRMA from giving ...

Antidepressants and Suicide Risk in Children and Adults: Using Evidence to Separate Fact from Fiction

Suicide is considered rare in non-depressed individuals but it occurs in between 5 and 15% of those suffering from depression.  The Columbia Suicide Severity Rating Scale (C-SSRS) is recommended for assessing an individual patient’s suicide risk.  Suicide risk factors in children, adolescents and adults include untreated depression, psychosis, access to firearms. Additional factors that increase suicide risk in children and adolescents include maternal depression, witnessing suicide attempts or sexual abuse or experiencing sexual abuse or trauma themselves.  Cyber-bullying is becoming more recognized as a contributing factor to suicide in youth.

FDA warning re: lamotrigine

Colleagues:   In case you haven’t already heard…   http://www.medscape.com/viewarticle/726845?src="">   Thanks, Marshall   Marshall E. Cates, Pharm.D., BCPP, FASHP ...

CDER New August 10, 2010

See link below for info on Hal Dec shortage.  Lynn Sent from my iPhone Begin forwarded message: From: "U.S. Food & Drug Administration (FDA)" < fda@service.govdelivery.com > Date: August 11, 2010 8:44:15 AM CDT ...

intuniv

is anyone using an autosub for intuniv to guanfacine IR?  If so what dosing did you use??     Thanks   Jessica Small, PharmD, BCPP Pharmacy Supervisor Aurora Psychiatric Hospital

Peramivir: An Intravenous Neuraminidase Inhibitor for the Treatment of 2009 H1N1 Influenza

OBJECTIVE: To review the efficacy and safety of peramivir, an
unapproved neuraminidase inhibitor recently granted an Emergency Use
Authorization (EUA) by the Food and Drug Administration (FDA) for the
treatment of 2009 H1N1 influenza in select patients.

Another Purported Alternative Therapy for Autism Called Out

Safety Of Purported Autism Treatment Called Into Question By The FDA. The Chicago Tribune (6/24, Tsouderos) reports that a letter sent on June 17 by the FDA to retired Kentucky chemist Boyd Haley "details five violations of the ...

Forest and Merz Announce FDA Approval of NAMENDA XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type

Forest and Merz Announce FDA Approval of NAMENDA XR for the Treatment of Moderate to Severe Dementia of the Alzheimer's Type NEW YORK, Jun 21, 2010 (BUSINESS WIRE) --Forest Laboratories, Inc. (NYSE: FRX) and Merz Pharmaceuticals GmbH announced ...